Author:
Ghazaryan Arevik,Wallace Jared A.,Tang William W.,Barba Cindy,Lee Soh-Hyun,Bauer Kaylyn M.,Nelson Morgan C.,Kim Carissa N.,Stubben Chris,Voth Warren P.,Rao Dinesh S.,O’Connell Ryan M.
Abstract
Graphical AbstractWe blocked pyruvate entry into mitochondria and decreased Oxidative Phosphorylation (OXPHOS) in human AML cell lines MV4-11 and MOLM-14 by using gene editing tools. This metabolic shift led to increased expression of miR-1 in the human AML cell lines. TARGET and TCGA AML patient sample dataset analysis revealed that miR-1 is overexpressed in patients with FLT3-ITD + mutation, and independently from FLT3-ITD, high levels of miR-1 also correlates with reduced survival. Transcriptional and metabolic profiling of miR-1 overexpressing AML cells revealed that miR-1 promotes OXPHOS through glutaminolysis. Moreover, the overexpression of miR-1 in AML cells exacerbated disease in a mouse xenograft model. Together, our work expands current knowledge within the field by uncovering novel connections between AML cell metabolism and miRNA expression that facilitates disease progression. Created with BioRender.com.
Funder
National Institutes of Health
Leukemia and Lymphoma Society
Subject
Genetics (clinical),Genetics,Molecular Medicine
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献